GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year. In an interview at the JP Morgan Healthcare Conference in San Francisco ...

GlaxoSmithKline’s new CEO Emma Walmsley is set to outline her vision for the company alongside half-year results next month – but reports suggest that she may shake up the consumer products ...

GlaxoSmithKline CEO Emma Walmsley made history in 2017, when she became the first woman to head up a major pharmaceutical company. In her first company presentation at an industry conference as ...

Drugs firm GSK (GlaxoSmithKline) has lifted its profits and sales growth targets for the year after a boost from cancer and HIV treatments. The firm’s boss, Emma Walmsley, hailed an “excellent ...

An American jury handed GlaxoSmithKline (GSK ... The latest victory will be a reassuring sign for chief executive Emma Walmsley as she pushes ahead with her turnaround strategy at the pharma ...

GlaxoSmithKline will combine its consumer ... and significant benefits to patients and consumers," said Emma Walmsley, chief executive of GSK. The Glaxo-Pfizer deal comes on a huge day for the ...

Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical ...

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases. During her eight years at ...

CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights the U.K. pharmaceutical company's refocused R&D strategy, with investments concentrated in the U.K., U.S ...

The British drugs group, led by boss Emma Walmsley, is using the data of 1.4m adults aged 65 and 66 to examine the impact of its Shingrix shot. GSK shares inched up 0.1 per cent, or 1p ...